ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 682817 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 682817; 2) Community: the network communities that were significantly associated with the response to NSC 682817; 3) Molecule: the relationships between components within communities and NSC 682817; 4) MDR: the compounds that were significantly associated with the NSC 682817.

NSC Compound Enrichment Correlation
NSC 756078 1-[5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl]-5-phenyl-1H-tetrazole 0.0474314077111082 -0.31264747
NSC 756173 GSK326090A 0.0474314077111082 -0.038718658
NSC 763564 EMD-534085 0.0474314077111082 -0.10885231
NSC 7811 Ammonium, [4-[[p-(dimethylamino)phenyl]imino]-2,5-cyclohexadien-1-ylidene]dimethyl-, chloride (8CI) 0.0474314077111082 0.10847546
NSC 87500 Solacongestidine 0.0474314077111082 -0.13168991
NSC 683252 Null 0.0480633950058471 -0.13276666
NSC 689297 1H-Pyrido[4,3,2-mn]thiazolo[4,5-b]acridin-9-one 0.0480633950058471 -0.091040337
NSC 693765 Null 0.0480633950058471 0.53695001
NSC 693985 Thymine, 1-[1,2-bis(ethoxycarbonyl)ethenyl]- 3-propynyl-, (Z)- 0.0480633950058471 -0.29257683
NSC 694269 Benzimidazo[1,2-a][1,8]naphthyridin-7-ium, 6-cyano-5-[[2-(3-methoxyphenyl)ethyl]amino]- 7-methyl-, 4-methylbenzenesulfonate 0.0480633950058471 -0.15007695
Total:65  Current:60    [First] [Prev] [Next] [Last]